🇺🇸 FDA
Patent

US 10894087

Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds

granted A61KA61K47/60A61P

Quick answer

US patent 10894087 (Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds) held by Nektar Therapeutics expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K47/60, A61P, A61P35/00